The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and tolerability of weekly 40mg/m² cisplatin radiosensitizing modified regimen for locally-advanced head and neck squamous cell carcinoma radical treatment with chemoradiotherapy: A university hospital experience.
 
Bruna Bighetti
No Relationships to Disclose
 
José Tristão Neto
No Relationships to Disclose
 
Renata do Socorro Monteiro Pereira
No Relationships to Disclose
 
LAÍS CRISTHINE SOUZA
No Relationships to Disclose
 
Ilka Lopes Santoro
No Relationships to Disclose
 
Hakaru Tadokoro
No Relationships to Disclose
 
Christian Ribas
No Relationships to Disclose
 
Ramon Andrade De Mello
Honoraria - Astellas Pharma; AstraZeneca; Merck Serono; Novartis; Novartis
Consulting or Advisory Role - MSD Oncology; Pfizer; Zodiac Pharma
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; BMS Brazil; Merck; Pierre Fabre; Roche